Incidence and Clinical Significance of Recompensation After HCV Cure
Clinical Gastroenterology and Hepatology · 2025-12 · 23 (13) · 2488-2498.e8
DOI: 10.1016/j.cgh.2025.04.026 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-12. Verfasst von Georg Semmler und 32 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic La…. Hauptthemen laut MEDLINE: Antiviral Agents, Liver Cirrhosis, Hepatitis C, Chronic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinischen Hochschule Hannover, Medizinische Universität Wien, Instituto de Investigación Sanitaria Gregorio Marañón.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine…
- Liver Unit, Hospital Clínic, IDIBAPS-FCRB, Universitat de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain.
- Liver Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.
- Liver Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain.
- Liver Unit, Digestive Diseases Division, Vall d'Hebron University Hospital, Vall d'Hebron Institut of Research, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Gastroenterology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, European Reference Network on Hepatological Diseases, Bologna, Italy.
Förderung
- Medizinischen Hochschule Hannover
- Medizinische Universität Wien
- Instituto de Investigación Sanitaria Gregorio Marañón
- Universidad Complutense de Madrid
Zitieren
APA
Semmler, G., Lens, S., Hidalgo, Á., Alonso López, S., Perez-Perez, M., Dajti, E., Kabelitz, M., Zanaga, P., Hofer, B. S., Marino, Z., Manzano, M. L., Payeras, I., Pons, M., Bruni, A., Zanetto, A., Burghart, L., Ecker, D., Simonis, L., Pocurull, A., …, & HCV Recompensation Study Group (2025). Incidence and Clinical Significance of Recompensation After HCV Cure. Clinical Gastroenterology and Hepatology, 23(13), 2488-2498.e8. https://doi.org/10.1016/j.cgh.2025.04.026
Vancouver
Semmler G, Lens S, Hidalgo Á, Alonso López S, Perez-Perez M, Dajti E, et al. Incidence and Clinical Significance of Recompensation After HCV Cure. Clinical Gastroenterology and Hepatology. 2025;23(13):2488-2498.e8. doi:10.1016/j.cgh.2025.04.026
BibTeX
@article{Semmler2025,
author = {Semmler, Georg and Lens, Sabela and Hidalgo, Álvaro and Alonso López, Sonia and Perez-Perez, Maria and Dajti, Elton and Kabelitz, Martin and Zanaga, Paola and Hofer, Benedikt Silvester and Marino, Zoe and Manzano, Marisa Luisa and Payeras, Isabel and Pons, Monica and Bruni, Angelo and Zanetto, Alberto and Burghart, Lukas and Ecker, Dominik and Simonis, Lucie and Pocurull, Anna and Fritz, Laurenz and Collazos, Cristina and Neumayer, Daniela and Balcar, Lorenz and Jachs, Mathias and Reiberger, Thomas and Russo, Francesco Paolo and Maasoumy, Benjamin and Genesca, Joan and Bañares, Rafael and Forns, Xavier and Fernandez, Inmaculada and Mandorfer, Mattias and HCV Recompensation Study Group, HCV Recompensation Study Group},
title = {Incidence and Clinical Significance of Recompensation After HCV Cure},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {13},
pages = {2488--2498.e8},
doi = {10.1016/j.cgh.2025.04.026}
}
EUVIMED